Stocks To Watch: IREDA, GAIL, Vedanta, SBI, GAIL, Delhivery, JK Cement, And Others – News18
Last Updated:
Stocks to watch: Shares of firms like IREDA, GAIL, Vedanta, SBI, GAIL, Delhivery, JK Cement, and others will be in focus on Tuesday’s trade
Stocks To Watch
Stocks To Watch On April 15: Domestic markets wrapped up last week on a strong note, gaining nearly 2%, buoyed by positive global cues. In today’s trade, shares of ICICI Lombard, ICICI Prudential Life, IREDA, Dr. Reddy’s, GAIL, among others, will be in focus due to various news developments and fourth-quarter results.
ICICI Lombard, ICICI Pru Life, IREDA
Shares of ICICI Lombard, ICICI Prudential Life, and IREDA will be in focus in today’s trade as all three companies are scheduled to announce their quarterly earnings. Investors will closely monitor the financials and management commentary for cues on the sector’s outlook and company-specific performance.
GAIL India
GAIL India issued a tender on Friday to acquire up to a 26% stake in a liquefied natural gas (LNG) project in the United States. This move comes with an associated 15-year gas import deal and is part of India’s broader strategy to reduce its trade surplus with the U.S. and strengthen long-term energy security. The development aligns with New Delhi’s efforts to diversify gas sources while deepening energy ties with Washington.
Aurobindo Pharma
Aurobindo Pharma has received final approval from the United States Food and Drug Administration (USFDA) to manufacture and market Rivaroxaban Tablets USP, 2.5 mg — the generic equivalent of Janssen Pharmaceuticals’s blockbuster blood thinner drug, Xarelto 2.5 mg. The product is indicated to reduce the risk of major cardiovascular events and is a significant addition to Aurobindo’s growing portfolio of cardiovascular generics in the U.S. market.
Macrotech Developers
The long-standing brand dispute between the Lodha brothers — Abhishek and Abhinandan — has officially come to an end. The two have reached a formal settlement. As per the agreement, Abhishek Lodha, who leads Macrotech Developers, will hold exclusive rights to the ‘Lodha’ and ‘Lodha Group’ brand names. Abhinandan Lodha will continue to use the ‘House of Abhinandan Lodha’ (HoABL) branding for his ventures.
Dr. Reddy’s Laboratories
Dr. Reddy’s Laboratories found itself at the center of workforce speculation after a media report suggested the company was cutting 25% of its employee-related costs. However, the pharmaceutical major swiftly denied the claims in a formal filing to the stock exchanges, stating that the report was “factually incorrect.” The company reiterated its commitment to its employees and its ongoing business strategy.
Reliance Industries
Mukesh Ambani-led Reliance Industries has taken another step forward in expanding its shipping sector presence. Through one of its subsidiaries, the company has acquired an additional 10% stake in Nauyaan Shipyard Private Ltd. The stake, worth Rs 1.72 crore, strengthens Reliance’s long-term commitment to maritime and shipping infrastructure — a strategic segment it has been gradually investing in.
Vedanta
Vedanta is again facing regulatory scrutiny, this time in the state of Odisha. The Odisha State Pollution Control Board has levied a hefty penalty of Rs 71.16 crore against the company, citing mismanagement of fly ash at one of its facilities. Vedanta has denied the allegations and plans to challenge the order legally, arguing that it has maintained a track record of environmental compliance and that the penalty is unjustified.
Zydus Lifesciences
Zydus Lifesciences has announced it has received final approval from the USFDA to market Jaythari (Deflazacort) Tablets in the United States. This medication is used in the treatment of Duchenne muscular dystrophy (DMD), a rare and progressive genetic disorder causing muscle weakness in children. Zydus will now be able to offer a generic version of Emflaza in four different strengths in the U.S. market.
SBI
Following the Reserve Bank of India’s policy rate cut, the State Bank of India has reduced its Repo Linked Lending Rate (RLLR) by 25 basis points, bringing it down to 8.25%. The move is expected to make borrowing cheaper for customers and further stimulate credit growth in the economy.
Delhivery
Sahil Barua, the co-founder and CEO of logistics major Delhivery, has resigned from the board of Swiggy. The development was formally recorded by Swiggy on April 11. Barua continues in his role at Delhivery, and his exit from the Swiggy board marks a notable shift in the foodtech company’s board structure.
JK Cement
Cement manufacturer JK Cement is considering a fundraising proposal to raise Rs 500 crore through a private placement of non-convertible debentures (NCDs). The company’s board will meet on May 24 to discuss and potentially approve the plan. If cleared, the proposal will be presented to shareholders at the company’s upcoming 31st annual general meeting.
Persistent Systems
IT firm Persistent Systems is merging its wholly-owned subsidiary, Capiot Software, into the parent company. The merger has received approval from the National Company Law Tribunal (NCLT) and is part of Persistent’s efforts to consolidate operations and streamline its business structure for improved efficiency and synergy.
HCL Tech
HCL Technologies continues to build momentum in the cloud space, having earned three new Google Cloud Partner specialisations. The certifications are in the domains of generative AI services, cloud migration, and infrastructure modernisation. These specialisations bolster HCL Tech’s digital transformation capabilities and strategic partnership with Google Cloud.
Disclaimer:Disclaimer: The views and investment tips by experts in this News18.com report are their own and not those of the website or its management. Users are advised to check with certified experts before taking any investment decisions.
